“He remains alert and no evidence of physical deterioration noted”. iv) The Claimant was admitted to the hospital on 22 August with atrial fibrillation and a heart rate of 140 beats per minute – but no other symptoms. He was assessed in the A&E Unit, and transferred, not to “Resuscitation”, but to the Acute Medical Unit. Expressly noted in the records – because he must have been specifically asked about these possible symptoms – is that he did not complain of chest pain, syncope, sweating or nausea. His vital signs were good, and his condition is expressly noted to be “stable”. v) The Claimant relies upon the fact that a vulnerable persons report was opened on his admission to hospital; but no such report was in fact opened. In its Response to Claimant’s Questions15 January 2103 , Answer 2 (prepared by the Clinical Pharmacology Team which includes Dr George), the hospital explained that the Claimant’s mother raised the issue of the Claimant’s vulnerability on 28 August, but he was found not to fulfil the relevant criteria. There is a reference to him being a vulnerable adult in a proforma nursing patient care plan dated25 October 2012 ; but that form is incomplete and unsigned, and that plan was never instituted. No safeguarding alert was ever raised about the Claimant. vi) However, thyroid tests on admission showed the Claimant to be severely thyrotoxic. There is no mystery about that condition. One of the drugs that had been used to maintain the Claimant’s heart rhythm, since well before he was detained in prison, was amiodarone, a drug that tends to be reserved for use when other agents have failed because of a number of well-known serious potential side effects including thyroid problems. In response to a raised thyroid level, and after liaison with the Claimant’s cardiologist, amiodarone was stopped by the prison doctor on2 August 2012 . However, as Professor Martin explained (in his30 January 2013 Statement, paragraph 8), even after discontinuation, the drug typically remains in the body for up to 300 days and its side effects might be delayed. As a result, the control of the thyrotoxicosis in that period may be difficult. Difficulties can be compounded by the need to replace the drug with other therapy to steady the heart beat, and the fact that thyrotoxicosis may be accompanied by significant weight loss and muscle weakness, with all that that entails, including speaking and feeding problems. Various witnesses, including the Claimant himself and his mother, refer to various signs and symptoms that he increasingly suffered during his seven weeks in prison. However, they were predominantly signs and symptoms typical of thyrotoxicosis. The various medical practitioners appear agreed that the exacerbation of the Claimant’s Friedreich’s ataxia – including, for example, his problems with motor function, swallowing and speech – was a result of his thyrotoxicosis (see, e.g., the discharge summary22 December 2012 , referring to the opinion of the Claimant’s consultant neurologist, Dr Giunti). The thyrotoxicosis did not result from his treatment in the prison, but from his longstanding use of a drug to stabilise his heart rhythm. vii) About 24 hours after he had been admitted to the hospital, the Claimant was transferred to the Critical Care Unit where he was treated with a battery of drugs and was put onto a ventilator. He contracted some sort of secondary infection, noted in blood tests – and there was evidence of secondary clinical pneumonia (Response to Claimant’s Questions15 January 2103 , Answer 7). Although the Claimant was “very unwell”, Professor Martin explains that he was not at any immediate risk of death (30 January 2013 Statement, paragraph 5). He improved on a daily basis, and was extubated on28 August 2012 . He continued to improve, and by November 2011 he had been clinically stable for several weeks; although the symptoms of thyrotoxicosis take a long time to resolve – often months – and, although his underlying condition would of course unfortunately but inevitably continue to decline, the Claimant was expected to continue to improve from those particular symptoms. viii) Therefore, there is simply no evidential basis upon which to base an assertion that the Claimant’s life was in danger because of his time and treatment in prison. Professor Martin’s evidence is directly to the contrary. ix) Nor is there any evidential basis for the assertion that the Claimant’s life expectancy has been reduced by his imprisonment. Ms Krause’s submission is based upon the premise that the Claimant’s substantial deterioration in health whilst in prison was due to his treatment there: she specifically relied upon the discharge summary dated22 December 2012 (prepared by Dr George), where it is said: “Daniel is significantly more frail at present than he was when admitted to [the prison]”
“Friedreich’s ataxia is an irreversible, progressive neurological disorder. Therefore, whilst it is true that Mr Hall’s overall condition has deteriorated over the last year and the deterioration is likely to be permanent, it is not possible to state that any deterioration has been disproportionate to a combination of his underlying condition and thyrotoxicosis and its consequences. It is impossible to say whether any permanent deterioration is specifically attributable to the events of August 2012. Similarly, a reduced life expectancy is consistent with the natural progression of this disease and it is not possible to say whether Mr Hall’s recent admission has had any effect on this.” xi) On 21 November, there was a multi-disciplinary team (“MDT”) meeting between the clinicians at the hospital and the healthcare staff of the prison, which determined, as a clinical judgment, that the Claimant’s medical needs could be met outside an acute hospital setting; but the actual discharge was delayed “to ensure that a full package of care could be arranged” (see Dr George4 January 2013 Statement, paragraphs 7-8). It is clear from the minutes of that meeting that the hospital would not discharge the Claimant unless themselves satisfied that the prison would be able to provide all appropriate care services: “It was agreed that [the Claimant] would be transferred back to [the prison] at the point when his clinical needs could be met in the community and that the level of care expected in the community setting would be the level of care expected on transfer. Therefore, the various out-patient and community services that would be normally arranged by [the hospital] on discharge, would have to be in place, in the setting of [the prison], prior to transfer.”
“It was made clear at the end of the meeting that [the hospital] team were of the opinion that it was safe for [the Claimant] to be discharged to the prison and the representatives of [the prison] were clear that they could offer the level of medical, nursing, physiotherapy and speech and language therapy needs, as stipulated by [the hospital] team”
“No one shall be subjected to torture or to inhuman or degrading treatment or punishment.”